Google stuns Wall Street with a corporate restructuring that includes renaming the company “Alphabet”.  Matt Argersinger and Jason Moser analyze the pros and cons of the move, including Google’s ability to invest in long-shot initiatives. Plus we discuss Shake Shake’s surprising profit and how short-sellers are helping to fuel the stock’s rise.

Berkshire-Hathaway shells out $37 billion for Precision Castparts, but Wall Street seems unimpressed. Neiman Marcus posts strong online sales as it gears up to go public. Plus we analyze Under Armour’s new partnership with the NBA and Twitter’s new deal with the NFL.

Are computers getting it wrong this earnings season? Did anyone foresee Disney’s stock falling this much? And what are we missing about the rise in the cost of college tuition?  Our man Morgan Housel helps us dip into the Fool Mailbag.

Walt Disney single-handedly drags down the Dow. DreamWorks Animation continues to struggle. Zillow bounces back on stronger-than-expected 2^nd-quarter results. And Lumber Liquidators drops to its lowest point in nearly 4 years.

CVS Health shares drop, despite strong Q2 profits. Regeneron Pharmaceuticals, the $60-billion biotech, hits an all-time high.  We discuss how to start investing in biotechnology stocks, and why Tommy’s Pizza has the best wings in New Jersey.

ExxonMobil’s earnings were cut in half. Tyson Foods falls as the beef market conditions worsen.  Plus we debate the prospects for Taco Bell’s new alcohol sales and encourage everyone to not freak out no matter what happens to the market this month.